Avita Medical Inc.

RCEL | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.66

+$0.82 (+7.56%)

Sep 22, 2026, 11:54 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+7.56%

(1D)

Rating

Updated: Aug 13, 2026

Fundamentals Average

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $289.55M

1D Range

10.71 11.81

52W Range

3.22 11.81

Valuation (TTM)

PE -0.30

PB -9.67

EV/EBITDA -7.27

Valuation (NTM)

Forward PE 28.83

Forward PEG 0.13

Price Target $11

Cash Flow

FCF Yield -12.5%

SBC Adj. FCF Yield -15.6%

SBC Impact -24.8%

Margins

Gross Margin 81.6%

Operating Margin -46.6%

FCF Margin -44.5%

Growth (CAGR)

Revenue 3Y | 5Y 22.8% | 20.9%

Dil EPS 3Y | 5Y -127.8% | -83.0%

FCF 3Y | 5Y 27.5% | -13.1%

Returns

ROA -90.2%

ROE 231.9%

ROIC -136.9%

Financial Health

Net Cash

$9.31M

Current Ratio 0.41

Interest Coverage -6.52

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’...

Sector Healthcare

Industry Medical - Devices

Employees 226

IPO Date May 13, 2012

Website avitamedical.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$11

Downside

-5.66%

Buy (4)

Hold (0)

Sell (0)

Analyst Details ➞